Panbela Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Panbela Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2013 to Q3 2024.
  • Panbela Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 11, 2024 was 4.85M shares, a 5.32% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.85M -273K -5.32% Nov 11, 2024 10-Q 2024-11-14
Q2 2024 4.85M +1.9M +64.1% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 4.85M -9.74M -66.7% Mar 22, 2024 10-K 2024-03-26
Q3 2023 5.13M -26.6M -83.8% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 2.96M -17.8M -85.8% Aug 7, 2023 10-Q 2023-08-10
Q1 2023 14.6M +1.15M +8.53% Mar 13, 2023 10-K 2023-03-16
Q3 2022 31.7M +18.3M +136% Nov 8, 2022 10-Q 2022-11-10
Q2 2022 20.8M +7.35M +54.7% Aug 12, 2022 10-Q 2022-08-15
Q1 2022 13.4M +3.37M +33.4% Mar 22, 2022 10-K 2022-03-24
Q3 2021 13.4M +3.78M +39.2% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 13.4M +6.36M +90% Aug 9, 2021 10-Q 2021-08-11
Q1 2021 10.1M +3.45M +52.1% Mar 23, 2021 10-K 2021-03-25
Q3 2020 9.65M +3.02M +45.5% Nov 11, 2020 10-Q 2020-11-12
Q2 2020 7.07M +1.35M +23.5% Aug 7, 2020 10-Q 2020-08-11
Q1 2020 6.63M +1.56M +30.8% Mar 20, 2020 10-K 2020-03-24
Q3 2019 6.63M +1.57M +31% Nov 8, 2019 10-Q 2019-11-13
Q2 2019 5.72M +662K +13.1% Aug 10, 2019 10-Q 2019-08-13
Q1 2019 5.07M +976K +23.9% Mar 15, 2019 10-K 2019-03-22
Q3 2018 5.06M +1.39M +37.9% Nov 3, 2018 10-Q 2018-11-05
Q2 2018 5.06M -31.6M -86.2% Aug 13, 2018 10-Q 2018-08-13
Q1 2018 4.09M -28.2M -87.3% Mar 19, 2018 10-K 2018-03-21
Q3 2017 3.67M -28.5M -88.6% Nov 10, 2017 10-Q 2017-11-14
Q2 2017 36.7M +4.82M +15.1% Aug 7, 2017 10-Q 2017-08-10
Q1 2017 32.3M +2.36M +7.89% Mar 27, 2017 10-K 2017-03-30
Q3 2016 32.2M +2.28M +7.64% Nov 7, 2016 10-Q 2016-11-10
Q2 2016 31.9M +30.4M +2098% Aug 8, 2016 10-Q 2016-08-11
Q1 2016 29.9M +28.4M +1961% Mar 1, 2016 10-K 2016-03-08
Q3 2015 29.9M +28.4M +1961% Nov 11, 2015 10-Q 2015-11-16
Q2 2015 1.45M 0 0% Jul 31, 2015 10-Q 2015-08-13
Q1 2015 1.45M 0 0% Mar 30, 2015 10-K 2015-03-30
Q3 2014 1.45M 0 0% Nov 10, 2014 10-Q 2014-11-14
Q2 2014 1.45M 0 0% Aug 13, 2014 10-Q 2014-08-14
Q1 2014 1.45M 0 0% Mar 21, 2014 10-K 2014-03-28
Q3 2013 1.45M Nov 14, 2013 10-Q 2013-11-14
Q2 2013 1.45M Aug 14, 2013 10-Q 2013-08-14
Q1 2013 1.45M Mar 25, 2013 10-K 2013-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.